Ost-müük Natera, Inc. - NTRA CFD
Lisa lemmikuks- Kokkuvõte
- Ajaloolised andmed
- Sündmused
- Tuluaruanne
- Bilanss
- Rahavood
- Omand
Hinnavahe | - | ||||||||
Pika positsiooni ööpäeva tasu
Long position overnight fee
Mine platvormile | -0.024068% | ||||||||
Lühikese positsiooni ööpäeva tasu
Short position overnight fee
Mine platvormile | 0.001846% | ||||||||
Ööpäeva tasu aeg | 21:00 (UTC) | ||||||||
Min kauplemise kogus | 1 | ||||||||
Valuuta | USD | ||||||||
Tagatis | 20% | ||||||||
Aktsiabörs | United States of America | ||||||||
Kauplemise vahendustasu | 0% |
*Information provided by Capital.com
Eelmine sulgemine* | N/A |
Avatud* | N/A |
Aastane muutus* | N/A |
Päeva ulatus* | N/A |
52 nädala ulatus | 27.35-59.75 |
Keskmine maht (10 päeva) | 1.15M |
Keskmine maht (3 kuud) | 28.75M |
Turukapitalisatsioon | 6.34B |
P/E suhtarv | -100.00K |
Ringluses olevad aktsiad | 113.29M |
Tulu | 820.22M |
EPS | -5.57 |
Dividendid (% kasumist) | N/A |
Beeta | 1.20 |
Järgmine tuluaruande kuupäev | May 3, 2023 |
Kõigi andmete allikas on Refinitiv, välja arvatud tärniga märgitud, kus *-ga andmed on esitanud Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Sulgemishind | Change (%) | Avamishind | High | Low |
---|
Natera, Inc. Events
Kellaaeg (UTC) (UTC) | Riik | Sündmus |
---|---|---|
No events scheduled |
- Aastas
- Kvartalis
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Kogutulu | 820.222 | 625.486 | 391.005 | 302.328 | 257.654 |
Tulu | 820.222 | 625.486 | 391.005 | 302.328 | 257.654 |
Kulud, Kokku | 456.256 | 318.418 | 203.62 | 175.47 | 166.055 |
Brutokasum | 363.966 | 307.068 | 187.385 | 126.858 | 91.599 |
Kogu tegevuskulu | 1361.26 | 1093.66 | 613.13 | 418.615 | 372.282 |
Müük/Üldine/admin kulud, kokku | 588.591 | 511.034 | 303.627 | 204.476 | 154.872 |
Uuringud ja arendus | 316.415 | 264.208 | 100.035 | 51.357 | 51.355 |
Tulud majandustegevusest | -541.04 | -468.174 | -222.125 | -116.287 | -114.628 |
Intressitulud (kulu), muud tulud, neto | -9.319 | -8.305 | -15.082 | -10.693 | -10.476 |
Muud, neto | 3.538 | 5.381 | 7.562 | 4.152 | -2.729 |
Netotulu enne makse | -546.821 | -471.098 | -229.645 | -122.828 | -127.833 |
Netotulu pärast makse | -547.799 | -471.716 | -229.743 | -124.827 | -128.154 |
Netotulu enne erikulusid | -547.799 | -471.716 | -229.743 | -124.827 | -128.154 |
Netotulu | -547.799 | -471.716 | -229.743 | -124.827 | -128.154 |
Arvestatav tulu, v a erikulud | -547.799 | -471.716 | -229.743 | -124.827 | -128.154 |
Arvestatav tulu, koos erikuludega | -547.799 | -471.716 | -229.743 | -124.827 | -128.154 |
Jaotamisele kuuluv netotulu | -547.799 | -471.716 | -229.743 | -124.827 | -128.154 |
Keskmine jaotamisele kuuluv aktsia kohta | 98.408 | 90.558 | 81.011 | 69.555 | 57.848 |
Jaotatav EPS, v a erakorralised kulud | -5.56661 | -5.20899 | -2.83595 | -1.79465 | -2.21536 |
Dividends per Share - Common Stock Primary Issue | 0 | ||||
Jaotamisele kuuluv normaal-EPS | -5.56661 | -5.20899 | -2.78903 | -1.91322 | -2.21536 |
Erakorralised kulud kokku | |||||
Ootamatud kulutused (tulu) | 0 | 0 | 5.848 | -12.688 |
Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | |
---|---|---|---|---|---|
Kogutulu | 217.252 | 210.637 | 198.2 | 194.133 | 173.028 |
Tulu | 217.252 | 210.637 | 198.2 | 194.133 | 173.028 |
Kulud, Kokku | 127.292 | 116.512 | 109.237 | 103.215 | 94.122 |
Brutokasum | 89.96 | 94.125 | 88.963 | 90.918 | 78.906 |
Kogu tegevuskulu | 359.025 | 329.689 | 341.285 | 331.263 | 312.694 |
Müük/Üldine/admin kulud, kokku | 143.822 | 147.667 | 149.468 | 147.634 | 146.761 |
Uuringud ja arendus | 87.911 | 65.51 | 82.58 | 80.414 | 71.811 |
Tulud majandustegevusest | -141.773 | -119.052 | -143.085 | -137.13 | -139.666 |
Intressitulud (kulu), muud tulud, neto | -2.752 | -2.33 | -2.15 | -2.087 | -2.079 |
Muud, neto | 2.373 | 0.087 | 0.277 | 0.801 | 1.151 |
Netotulu enne makse | -142.152 | -121.295 | -144.958 | -138.416 | -140.594 |
Netotulu pärast makse | -142.573 | -121.48 | -145.151 | -138.595 | -140.564 |
Netotulu enne erikulusid | -142.573 | -121.48 | -145.151 | -138.595 | -140.564 |
Netotulu | -142.573 | -121.48 | -145.151 | -138.595 | -140.564 |
Arvestatav tulu, v a erikulud | -142.573 | -121.48 | -145.151 | -138.595 | -140.564 |
Arvestatav tulu, koos erikuludega | -142.573 | -121.48 | -145.151 | -138.595 | -140.564 |
Jaotamisele kuuluv netotulu | -142.573 | -121.48 | -145.151 | -138.595 | -140.564 |
Keskmine jaotamisele kuuluv aktsia kohta | 104.408 | 97.052 | 96.579 | 95.578 | 94.842 |
Jaotatav EPS, v a erakorralised kulud | -1.36554 | -1.2517 | -1.50293 | -1.45007 | -1.48209 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | ||
Jaotamisele kuuluv normaal-EPS | -1.36554 | -1.2517 | -1.50293 | -1.45007 | -1.48209 |
Ootamatud kulutused (tulu) | 0 | 0 |
- Aastas
- Kvartalis
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Käibevarad kokku | 1093.14 | 862.663 | 523.167 | 240.518 | 180.625 |
Raha ja lühiajalised investeeringud | 914.282 | 737.274 | 440.991 | 153.868 | 118.867 |
Raha ja ekvivalendid | 84.386 | 48.668 | 61.926 | 46.407 | 12.62 |
Lühiajalised investeeringud | 829.896 | 688.606 | 379.065 | 107.461 | 106.247 |
Laekumata arved, neto | 122.074 | 78.565 | 53.351 | 62.223 | 44.089 |
Accounts Receivable - Trade, Net | 122.074 | 78.565 | 53.351 | 62.223 | 44.089 |
Total Inventory | 26.909 | 20.031 | 12.394 | 13.633 | 8.998 |
Prepaid Expenses | 29.645 | 26.606 | 16.376 | 6.197 | 8.612 |
Other Current Assets, Total | 0.228 | 0.187 | 0.055 | 4.597 | 0.059 |
Total Assets | 1236.49 | 932.153 | 582.656 | 268.171 | 214.613 |
Property/Plant/Equipment, Total - Net | 124.529 | 54.747 | 47.013 | 24.336 | 29.667 |
Property/Plant/Equipment, Total - Gross | 143.942 | 104.801 | 88.537 | 58.633 | 56.652 |
Accumulated Depreciation, Total | -19.413 | -50.054 | -41.524 | -34.297 | -26.985 |
Other Long Term Assets, Total | 18.82 | 14.743 | 12.476 | 3.317 | 4.321 |
Total Current Liabilities | 218.956 | 199.053 | 179.874 | 113.981 | 105.561 |
Accounts Payable | 27.206 | 8.096 | 8.604 | 14.587 | 8.529 |
Accrued Expenses | 114.854 | 71.689 | 54.03 | 33.843 | 35.558 |
Notes Payable/Short Term Debt | 50.052 | 50.054 | 50.123 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 50.153 | 50.112 | |||
Other Current Liabilities, Total | 26.844 | 69.214 | 67.117 | 15.398 | 11.362 |
Total Liabilities | 583.183 | 445.917 | 303.945 | 236.009 | 189.196 |
Total Long Term Debt | 280.394 | 202.493 | 73.656 | 73.357 | 73.065 |
Other Liabilities, Total | 83.833 | 44.371 | 50.415 | 48.671 | 10.57 |
Total Equity | 653.304 | 486.236 | 278.711 | 32.162 | 25.417 |
Preferred Stock - Non Redeemable, Net | 0 | ||||
Common Stock | 0.01 | 0.009 | 0.008 | 0.007 | 0.006 |
Additional Paid-In Capital | 2050.42 | 1411.29 | 976.955 | 607.236 | 472.552 |
Retained Earnings (Accumulated Deficit) | -1394.84 | -929.318 | -699.171 | -574.529 | -446.375 |
Other Equity, Total | -2.287 | 4.259 | 0.919 | -0.552 | -0.766 |
Total Liabilities & Shareholders’ Equity | 1236.49 | 932.153 | 582.656 | 268.171 | 214.613 |
Total Common Shares Outstanding | 95.14 | 86.223 | 78.005 | 62.083 | 54.04 |
Long Term Debt | 280.394 | 202.493 | 73.656 | 73.357 | 73.065 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Käibevarad kokku | 980.226 | 1093.14 | 1191.22 | 739.888 | 791.403 |
Raha ja lühiajalised investeeringud | 751.958 | 914.282 | 1023.7 | 580.243 | 653.572 |
Raha ja ekvivalendid | 158.298 | 84.386 | 95.103 | 62.811 | 65.126 |
Lühiajalised investeeringud | 593.66 | 829.896 | 928.596 | 517.432 | 588.446 |
Laekumata arved, neto | 167.862 | 122.074 | 110.416 | 100.13 | 87.562 |
Accounts Receivable - Trade, Net | 167.862 | 122.074 | 110.416 | 100.13 | 87.562 |
Total Inventory | 25.048 | 26.909 | 28.022 | 28.409 | 23.676 |
Prepaid Expenses | 35.13 | 29.645 | 28.858 | 30.878 | 26.43 |
Other Current Assets, Total | 0.228 | 0.228 | 0.228 | 0.228 | 0.163 |
Total Assets | 1144.66 | 1236.49 | 1311.37 | 849.956 | 893.512 |
Property/Plant/Equipment, Total - Net | 142.762 | 124.529 | 106.949 | 97.221 | 89.703 |
Property/Plant/Equipment, Total - Gross | 165.177 | 143.942 | 165.263 | 152.538 | 142.306 |
Accumulated Depreciation, Total | -22.415 | -19.413 | -58.314 | -55.317 | -52.603 |
Other Long Term Assets, Total | 21.676 | 18.82 | 13.202 | 12.847 | 12.406 |
Total Current Liabilities | 231.072 | 218.956 | 199.714 | 197.988 | 166.969 |
Accounts Payable | 18.07 | 27.206 | 8.181 | 20.307 | 4.682 |
Accrued Expenses | 130.919 | 114.854 | 114.18 | 93.183 | 81.711 |
Notes Payable/Short Term Debt | 50.055 | 50.052 | 50.049 | 50.049 | 50.052 |
Other Current Liabilities, Total | 32.028 | 26.844 | 27.304 | 34.449 | 30.524 |
Total Liabilities | 602.329 | 583.183 | 552.357 | 550.846 | 521.067 |
Total Long Term Debt | 280.706 | 280.394 | 280.085 | 279.777 | 279.471 |
Long Term Debt | 280.706 | 280.394 | 280.085 | 279.777 | 279.471 |
Other Liabilities, Total | 90.551 | 83.833 | 72.558 | 73.081 | 74.627 |
Total Equity | 542.335 | 653.304 | 759.017 | 299.11 | 372.445 |
Common Stock | 0.01 | 0.01 | 0.01 | 0.009 | 0.009 |
Additional Paid-In Capital | 2089.66 | 2050.42 | 2011.79 | 1399.66 | 1356.21 |
Retained Earnings (Accumulated Deficit) | -1533.43 | -1394.84 | -1254.27 | -1103 | -986.973 |
Other Equity, Total | -13.904 | -2.287 | 1.491 | 2.441 | 3.197 |
Total Liabilities & Shareholders’ Equity | 1144.66 | 1236.49 | 1311.37 | 849.956 | 893.512 |
Total Common Shares Outstanding | 96.259 | 95.14 | 94.538 | 88.498 | 87.43 |
- Aastas
- Kvartalis
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Netotulu/algväärtus | -471.716 | -229.743 | -124.827 | -128.154 | -137.628 |
Raha majandustegevusest | -335.236 | -182.512 | -63.444 | -70.581 | -97.825 |
Raha majandustegevusest | 11.254 | 8.613 | 7.73 | 7.501 | 7.143 |
Mittelikviidsed varad | 171.299 | 77.748 | 26.452 | 22.916 | 13.05 |
Cash Taxes Paid | 0.283 | 0.067 | 2.154 | 0.332 | 0.177 |
Makstud intressid | 7.077 | 3.296 | 12.455 | 7.914 | 3.568 |
Muutused tööjõus | -46.073 | -39.13 | 27.201 | 27.156 | 19.61 |
Tulu investeeringutelt | -205.193 | -331.461 | -266.353 | -5.161 | 13.784 |
Kapitalikulutused | -49.588 | -19.604 | -4.968 | -3.88 | -9.867 |
Muud rahavood investeeringutelt, kokku | -155.605 | -311.857 | -261.385 | -1.281 | 23.651 |
Rahavood investeeringutelt | 576.188 | 500.847 | 340.774 | 113.725 | 80.372 |
Aktsiate emiteerimine (tagasiost), neto | 576.188 | 301.288 | 340.774 | 113.725 | 5.659 |
Laenu väljastamine (kustutamine), neto | 0 | 199.559 | 0 | 0 | 75 |
Rahaline kogumuutus | 35.759 | -13.126 | 10.977 | 37.983 | -3.669 |
Rahavoogudesse investeerimine | 0 | -0.287 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Net income/Starting Line | -138.595 | -471.716 | -331.152 | -179.879 | -63.853 |
Cash From Operating Activities | -137.277 | -335.236 | -236.5 | -145.439 | -74.876 |
Cash From Operating Activities | 3.002 | 11.254 | 8.259 | 5.262 | 2.549 |
Non-Cash Items | 40.865 | 171.299 | 136.312 | 68.849 | 28.676 |
Cash Interest Paid | 0.159 | 7.077 | 3.69 | 3.538 | 0.152 |
Changes in Working Capital | -42.549 | -46.073 | -49.919 | -39.671 | -42.248 |
Cash From Investing Activities | 207.033 | -205.193 | -284.697 | 146.709 | 86.74 |
Capital Expenditures | -15.885 | -49.588 | -36.298 | -18.891 | -10.26 |
Other Investing Cash Flow Items, Total | 222.918 | -155.605 | -248.399 | 165.6 | 97 |
Cash From Financing Activities | 4.156 | 576.188 | 567.673 | 12.914 | 4.57 |
Issuance (Retirement) of Stock, Net | 4.156 | 576.188 | 567.673 | 12.914 | 4.57 |
Net Change in Cash | 73.912 | 35.759 | 46.476 | 14.184 | 16.434 |
Issuance (Retirement) of Debt, Net | 0 | 0 | 0 |
Investori nimi | Investori liik | Ringluse protsent | Hoitud osakud | Muutus osakutes | Hoidmise kuupäev | Hinnang käibele |
---|---|---|---|---|---|---|
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 8.7594 | 9923131 | 1628200 | 2022-12-31 | LOW |
Fred Alger Management, LLC | Investment Advisor/Hedge Fund | 7.9205 | 8972823 | 191477 | 2022-12-31 | MED |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 4.2045 | 4763130 | 715214 | 2022-12-31 | LOW |
Samlyn Capital, LLC | Hedge Fund | 3.8755 | 4390372 | 2113236 | 2022-12-31 | HIGH |
JP Morgan Asset Management | Investment Advisor | 3.739 | 4235761 | 101390 | 2022-12-31 | LOW |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 3.1533 | 3572262 | 764812 | 2022-12-31 | LOW |
Sofinnova Investments, Inc | Venture Capital | 2.7369 | 3100560 | -2400 | 2022-12-31 | MED |
Citadel Advisors LLC | Hedge Fund | 2.6914 | 3048948 | 884865 | 2022-12-31 | HIGH |
Norges Bank Investment Management (NBIM) | Sovereign Wealth Fund | 2.4544 | 2780428 | 1886903 | 2022-12-31 | LOW |
Eversept Partners, LP | Hedge Fund | 2.371 | 2685959 | 1260357 | 2022-12-31 | MED |
RTW Investments L.P. | Investment Advisor/Hedge Fund | 2.3033 | 2609283 | 400000 | 2022-12-31 | LOW |
Kynam Capital Management LP | Hedge Fund | 2.2979 | 2603207 | 584847 | 2022-12-31 | HIGH |
Principal Global Investors (Equity) | Investment Advisor | 1.7724 | 2007860 | 867205 | 2022-12-31 | LOW |
OrbiMed Advisors, LLC | Investment Advisor/Hedge Fund | 1.7181 | 1946353 | 441200 | 2022-12-31 | LOW |
Avidity Partners Management LP | Hedge Fund | 1.5879 | 1798900 | 63900 | 2022-12-31 | HIGH |
Pictet Asset Management Ltd. | Investment Advisor/Hedge Fund | 1.5711 | 1779828 | 184128 | 2022-12-31 | LOW |
Braidwell LP | Hedge Fund | 1.4309 | 1621012 | 1621012 | 2022-12-31 | |
D. E. Shaw & Co., L.P. | Hedge Fund | 1.3493 | 1528566 | -53493 | 2022-12-31 | MED |
Marshall Wace LLP | Investment Advisor/Hedge Fund | 1.3171 | 1492125 | 262940 | 2022-12-31 | HIGH |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 1.3059 | 1479376 | 217067 | 2022-12-31 | LOW |
Miks valida Capital.com? Meie numbrid räägivad iseenda eest.
Capital.com Group500K+
Kauplejad
92K+
Igakuiste aktiivsete klientide arv
$53M+
Igakuine investeerimise maht
$30M+
Igakuiselt välja võetud
Kauplemiskalkulaator
Arvutage oma hüpoteetiline võit/kaotus, kui oleksite avanud CFD-tehingu ühel kindlal kuupäeval (valige kuupäev) ja sulgenud teisel kuupäeval (valige kuupäev).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Natera, Inc. Company profile
Ettevõttest Natera, Inc.
Natera, Inc. on diagnostikaettevõte. Ettevõte keskendub molekulaarse testimise teenuste arendamisele ja turustamisele, rakendades oma tehnoloogiat naiste tervise, onkoloogia ja elundite tervise valdkonnas. Ettevõtte rakuvaba DNA (cfDNA) tehnoloogia ühendab tema molekulaarsed testid, mis mõõdavad usaldusväärselt paljusid informatiivseid piirkondi kogu genoomis nii väikestest proovidest kui ühest rakust. Ettevõtte tootevalikusse kuuluvad Panorama Non-Invasive Prenatal Test (NIPT), Vistara, Horizon Carrier Screening (HCS), Spectrum Pre-implantation Genetics (Spectrum), Anora Miscarriage Test (Anora), Non-Invasive Paternity Testing (PAT) ja Prospera. Ettevõte pakub ka Constellationi, pilvepõhist tarkvaraplatvormi, mis võimaldab laboratooriumide klientidele pilve kaudu juurdepääsu ettevõtte algoritmidele ja bioinformaatikale, et valideerida ja käivitada ettevõtte tehnoloogial põhinevaid teste.
Industry: | Laboratory Diagnostic & Testing Substances |
13011 Mccallen Pass
Building A Suite 100
AUSTIN
TEXAS 78753
US
Tuluaruanne
- Annual
- Quarterly
Teised on vaadanud veel
Kas otsite jätkuvalt vahendajat, keda saab usaldada?
Ühinege 500,000+ kauplejaga üle kogu maailma, kes valisid kauplemiseks veebisaidi Capital.com